Recombinant Sendai virus vectors for activated T lymphocytes - Okano, S; Yonemitsu, Y; Nagata, S; Sata, S; Onimaru, M; Nakagawa, K; Tomita, Y; Kishihara, K; Hashimoto, S; Nakashima, Y; Sugimachi, K; Hasegawa, M; et al. (Gene therapy, 2003)
Keywords: Animals; Antigens; Biological and medical sciences; Biomedical and Life Sciences; Biomedicine; Care and treatment; Cell activation; Cell Biology; Cell Line; Centrifugation; Cytoplasm; Expression vectors; Female; Fundamental and applied biological sciences. Psychology; Gene Expression; Gene Therapy; Genetic aspects; Genetic Therapy - methods; Genetic Vectors - administration & dosage; Genetic Vectors - genetics; Green fluorescent protein; Green Fluorescent Proteins; Health aspects; Human Genetics; Humans; Immunologic diseases; Immunotherapy, Adoptive - methods; Luminescent Proteins - genetics; Lymphocyte Activation; Lymphocytes; Lymphocytes T; Methods; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Molecular and cellular biology; Nanotechnology; Physiological aspects; Polybrene; Protamine sulfate; Receptors, Antigen, T-Cell - genetics; Receptors, Antigen, T-Cell - metabolism; research-article; Sendai virus - genetics; T cells; T-Lymphocytes - metabolism; Time Factors; Canada; Japan; gene therapy; Sendai virus vector; enhanced green fluorescent protein gene; T cells; Genetics